Dr Qiao-Xin Li, is a Senior Research Fellow at the Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Australia. She is also the manager of the National Dementia Diagnostics laboratory (NDDL). The NDDL is a NATA accredited test laboratory to perform the diagnostic testing for Alzheimer’s disease (three proteins of amyloid42, tau and phospho-tau) in cerebrospinal fluid (CSF); as well as accredited to perform 14-3-3 protein detection in CSF, with approximately 90% sensitivity and specificity for sporadic Creutzfeldt Jakob disease (CJD).
The NDDL offers its diagnostic services to the medical community, scientific researchers and the pharmaceutical industry. Dr Li is a biochemist with strong interest in neurodegenerative diseases and blood biomarkers, as attested from the list of publications of more than 100 original research articles. She is a member of the AIBL biomarker team since its inception in 2007.
Brain health affects all Australians. You can support our research by making a donation or a bequest.